Alzamend Neuro, Inc.

For the period ended Apr 30, 2026. Filed Jul 22, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jul 22, 2026

ALZN$1.41-9.0%Stored close · as of Nov 6, 2026

Opening this filing…